Dr Reddys Laboratories (RDY) Profit After Tax (2012 - 2026)

Dr Reddys Laboratories' Profit After Tax history runs 15 years deep, the most recent figure standing at $24.1 million for Q1 2026.

• In Q1 2026, Profit After Tax fell 86.84% year-over-year to $24.1 million; the TTM figure through Mar 2026 stood at $486.0 million (down 67.88% YoY), while the FY2026 annual figure was $452.0 million, down 32.64% from the prior year.
• Profit After Tax was $24.1 million for Q1 2026 at Dr Reddys Laboratories, down from $133.6 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $996.4 million in Q3 2024 to a low of -$1.9 billion in Q1 2024.
• Historically, Profit After Tax has averaged $111.1 million across 5 years, with a median of $164.7 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Profit After Tax surged 117786349.35% in 2023, then tumbled 1241.97% in 2024.
• A 5-year view of Profit After Tax shows it stood at $117.0 million in 2022, then soared by 665.04% to $895.1 million in 2023, then plunged by 81.43% to $166.3 million in 2024, then dropped by 19.65% to $133.6 million in 2025, then tumbled by 81.94% to $24.1 million in 2026.
• The last three Profit After Tax figures came in at $24.1 million (Q1 2026), $133.6 million (Q4 2025), and $163.6 million (Q3 2025), per Business Quant data.